ESRP2 and hepatocellular carcinoma: Additionally, the IC50 of Takinib was significantly increased upon ESRP2 ectopic expression, but decreased as a result of ESRP2 knockdown (Figure 7A), indicating that ESRP2 deficiency sensitizes HCC cells to TAK1 inhibition.